Covered recipient · General Payments record
KATHERINE S HU
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2024
$2,602.90
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,163.68 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $603.35 | 8 |
| Dompe US, Inc. | $151.00 | 2 |
| Amgen Inc. | $121.84 | 1 |
| Carl Zeiss Meditec USA, Inc. | $88.17 | 3 |
| Harrow Eye, LLC | $85.58 | 1 |
| GLAUKOS CORPORATION | $81.46 | 1 |
| BIOTISSUE HOLDINGS INC. | $16.27 | 1 |
| ABBVIE INC. | $16.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.01 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103947138 | CMS |
| Alcon Vision LLC | $78.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696057 | CMS |
| Alcon Vision LLC | $39.18 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696053 | CMS |
| Alcon Vision LLC | $51.60 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696055 | CMS |
| Alcon Vision LLC | $25.63 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696051 | CMS |
| Alcon Vision LLC | $120.74 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696059 | CMS |
| Alcon Vision LLC | $149.46 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696063 | CMS |
| Alcon Vision LLC | $6.23 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696049 | CMS |
| Alcon Vision LLC | $131.57 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696061 | CMS |
| Amgen Inc. | $121.84 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111602488 | CMS |
| BIOTISSUE HOLDINGS INC. | $16.27 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148766442 | CMS |
| Carl Zeiss Meditec USA, Inc. | $37.58 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153262940 | CMS |
| Carl Zeiss Meditec USA, Inc. | $16.09 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153262938 | CMS |
| Carl Zeiss Meditec USA, Inc. | $34.50 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153262942 | CMS |
| Dompe US, Inc. | $120.07 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407989 | CMS |
| Dompe US, Inc. | $30.93 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407991 | CMS |
| Glaukos Corporation | $81.46 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151985428 | CMS |
| Harrow Eye, LLC | $85.58 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145605254 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.